Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemorrhagic Fever, Ebola”

125 trials

Showing 20 of 125 results

Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Testing effectiveness (Phase 2)WithdrawnNCT04268966
What this trial is testing

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

Who this might be right for
Ebola Virus Disease
Jazz Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02818582
What this trial is testing

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

Who this might be right for
Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableStudy completedNCT02933931
What this trial is testing

Immune Durability After VSV-EBOV Vaccination

Who this might be right for
Immune ResponseVaccinationDurability
University Hospital, Geneva 95
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02485301
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 3,024
Testing effectiveness (Phase 2)Ended earlyNCT02739477
What this trial is testing

Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

Who this might be right for
Ebola Virus Survivor
Institut National de la Santé Et de la Recherche Médicale, France 2
Post-approval studies (Phase 4)Not Yet RecruitingNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Testing effectiveness (Phase 2)Study completedNCT02289027
What this trial is testing

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Who this might be right for
Ebola Vaccines
Centre Hospitalier Universitaire Vaudois 120
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Early research (Phase 1)Ended earlyNCT01518881
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 24
Early research (Phase 1)Study completedNCT02464670
What this trial is testing

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Who this might be right for
Ebola Vaccine
Inovio Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT02344407
What this trial is testing

Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Early research (Phase 1)Study completedNCT02325050
What this trial is testing

A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 164
Early research (Phase 1)Study completedNCT03478891
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 19
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Testing effectiveness (Phase 2)Study completedNCT04028349
What this trial is testing

ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)

Who this might be right for
Ebola Virus Disease
MRC/UVRI and LSHTM Uganda Research Unit 800
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Testing effectiveness (Phase 2)UnknownNCT02380625
What this trial is testing

Multiple Treatments for Ebola Virus Disease (EVD)

Who this might be right for
Ebola Virus Disease
Clinical Research Management, Inc. 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation